Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis

We herein report the case of a 57-year-old woman presenting with a biopsy-proven tumefactive demyelinating lesion as her first clinical event. Subsequently, she displayed a relapsing-remitting course with recurrence of large demyelinating lesions exceeding 2 cm in diameter rather than the small ovoi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Intern Med
Hlavní autoři: Nakamura, Masataka, Itani, Kumi, Miyake, Kousuke, Kunieda, Takenobu, Kaneko, Satoshi, Kusaka, Hirofumi
Médium: Artigo
Jazyk:Inglês
Vydáno: The Japanese Society of Internal Medicine 2017
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5337470/
https://ncbi.nlm.nih.gov/pubmed/28090055
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky